Prognostic and Clinicopathological Significance of Epidermal Growth Factor Receptor (EGFR) Expression in Oral Squamous Cell Carcinoma: Systematic Review and Meta-Analysis
International Journal of Molecular Sciences · 25.07.2023 · 24 (15) · 11888
DOI: 10.3390/ijms241511888 ↗Kurz gefasst
Metaanalyse in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 25.07.2023. Verfasst von José Luis Cívico-Ortega und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Dentistry, University of Granada, 18071 Granada, Spain. Hauptthemen laut MEDLINE: Carcinoma, Squamous Cell, Mouth Neoplasms, Head and Neck Neoplasms. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The aim of this systematic review and meta-analysis was to evaluate the current evidence in relation to the clinicopathological and prognostic significance of epidermal growth factor receptor (EGFR) overexpression in patients with oral squamous cell carcinoma (OSCC). We searched MEDLINE/PubMed, Embase, Web of Science, and Scopus for studies published before November 2022. We evaluated the quality of primary-level studies using the QUIPS tool, conducted meta-analyses, examined inter-study heterogeneity via subgroup analyses and meta-regressions, and performed small-study effects analyses. Fifty primary-level studies (4631 patients) met the inclusion criteria. EGFR overexpression was significantly associated with poor overall survival (hazard ratio [HR] = 1.38, 95% confidence intervals [CI] = 1.06–1.79, p = 0.02), N+ status (odds ratio [OR] = 1.37, 95%CI = 1.01–1.86, p = 0.04), and moderately–poorly differentiated OSCC (OR = 1.43, 95% CI = 1.05–1.94, p = 0.02). In addition, better results were obtained by the application of a cutoff point ≥10% tumor cells with EGFR overexpression (p < 0.001). In conclusion, our systematic review and meta-analysis supports that the immunohistochemical assessment of EGFR overexpression may be useful as a prognostic biomarker for OSCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Dentistry, University of Granada, 18071 Granada, Spain.
- Instituto de Investigación Biosanitaria ibs.GRANADA, 18012 Granada, Spain.
- Hospital Universitario San Juan de Reus, CAP Marià Fortuny, 43204 Tarragona, Spain.
ORCID-Profile: Pablo Ramos-García, Miguel Ángel González-Moles
Zitieren
APA
Cívico-Ortega, J. L., González-Ruiz, I., Ramos-García, P., Cruz-Granados, D., Samayoa-Descamps, V., & González-Moles, M. Á. (2023). Prognostic and Clinicopathological Significance of Epidermal Growth Factor Receptor (EGFR) Expression in Oral Squamous Cell Carcinoma: Systematic Review and Meta-Analysis. International Journal of Molecular Sciences, 24(15), 11888. https://doi.org/10.3390/ijms241511888
Vancouver
Cívico-Ortega JL, González-Ruiz I, Ramos-García P, Cruz-Granados D, Samayoa-Descamps V, González-Moles MÁ. Prognostic and Clinicopathological Significance of Epidermal Growth Factor Receptor (EGFR) Expression in Oral Squamous Cell Carcinoma: Systematic Review and Meta-Analysis. International Journal of Molecular Sciences. 2023;24(15):11888. doi:10.3390/ijms241511888
BibTeX
@article{CvicoOrtega2023,
author = {Cívico-Ortega, José Luis and González-Ruiz, Isabel and Ramos-García, Pablo and Cruz-Granados, David and Samayoa-Descamps, Valerie and González-Moles, Miguel Ángel},
title = {Prognostic and Clinicopathological Significance of Epidermal Growth Factor Receptor (EGFR) Expression in Oral Squamous Cell Carcinoma: Systematic Review and Meta-Analysis},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {15},
pages = {11888},
doi = {10.3390/ijms241511888}
}
EUVIMED